BCYC Q3 2020 Earnings — Bicycle Therapeutics plc Revenue & Financial Results | Market Cap Arena

BCYCBicycle Therapeutics plc

$360M

Q3 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$4M+525.7% YoY

Gross Profit

$4M100.0% margin

Operating Income

-$11M-277.9% margin

Net Income

-$10M-263.9% margin

EPS (Diluted)

$-0.52

QoQ Revenue Growth

+144.6%

Cash Flow

Operating Cash Flow

-$10M

Free Cash Flow

-$10M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$170M

Total Liabilities

$61M

Stockholders' Equity

$110M

Cash & Equivalents

$150M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4M	$614,000	+525.7%
Gross Profit	$4M	-$5M	+170.3%
Operating Income	-$11M	-$10M	-4.1%
Net Income	-$10M	-$9M	-6.9%